DNA Today Podcast Series
Mark Kiel on Rare
Disease Genetics
DNA Today is an award-winning podcast that explores the impact of genetics on our health through conversations with industry leaders. In the latest episode, Mark Kiel, founder, and chief science officer of Genomenon, unpacked the complex genetics of ALS, and how Genomenon’s innovative technology is helping diagnose and treat patients with all rare genetic diseases and cancer.
Discussed in this episode:
- The causes of ALS and how it is diagnosed
- The availability of genetic testing for ALS patients’ family members
- Key findings from Genomenon’s Comprehensive Genomic Landscape for ALS, including actionable trends
- How these findings can assist in shaping ALS clinical trials, as well as help genetic counselors better advise patients and families
| WATCH THE INTERVIEW |
Haven’t tried Mastermind? Create your free account and start searching today.
About Genomenon
Genomenon is an AI-driven genomics company that organizes the world’s genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer.
Genomenon was named Global Company of the Year in Clinical Genomics Interpretation by Frost & Sullivan.
